Results 41 to 50 of about 4,273 (174)

A case of unplanned pregnancy at 2 months after uterine curettage in a patient with a hydatidiform mole

Journal of International Medical Research, 2020
Whether an unplanned pregnancy should be terminated during follow-up of a hydatidiform mole is controversial. We report a patient who had an unplanned pregnancy with a hydatidiform mole at 2 months after uterine curettage when the human chorionic ...
Jie-Qiong Cao, Ye Zhao, Ying Ma, Qiu-Man Wang, Li-Na Niu, Si Qiao   +5 more
doaj   +1 more source

Essential embryology for the Canadian pathologists’ assistant

Anatomical Sciences Education, Volume 19, Issue 7, Page 1134-1156, July 2026.
Abstract Pathologists' assistants (PAs) are pivotal in healthcare, conducting autopsies and examining tissues under a pathologist's guidance. Embryology knowledge is crucial for PAs to accurately assess anomalies and identify pathologies. Yet, it is often overlooked in academic PA training programs.
Samantha H. Nacci, William Tsui, Fang‐I Lu, Avrum I. Gotlieb, Danielle C. Bentley   +4 more
wiley   +1 more source

Prevalence, Associated Factors, and Evaluation of Clinical and Biochemical Indices of Gestational Trophoblastic Tumors in Patients Referring to Imam Reza Hospital, Kermanshah: A Five‐Year Analytical Study (2017–2022)

Health Science Reports, Volume 9, Issue 7, July 2026.
ABSTRACT Background and Aims Gestational trophoblastic neoplasia (GTN) encompasses a spectrum of pregnancy‐related disorders and poses significant clinical challenges. Understanding its prevalence, clinical characteristics, and associated risk factors is essential for timely diagnosis and management.
Nasrin Mansouri, Ali Azizi, Samira Sajadi Asl, Zahra Javanbakht, Marzieh Bagherinia   +4 more
wiley   +1 more source

Characterization of apoptosis and autophagy through Bcl-2 and Beclin-1 immunoexpression in gestational trophoblastic disease

Iranian Journal of Reproductive Medicine, 2015
Background: The pathogenesis of Gestational Trophoblastic Disease (GTD) is not clearly known. Objective: In this study, immunoexpression of proteins Bcl-2 and Beclin-1 in trophoblastic lesions and normal trophoblastic tissue was conducted to study the ...
Teresa Liliana Wargasetia, Nurhalim Shahib, Djamhoer Martaadisoebrata, Diah Dhianawaty, Bethy Hernowo   +4 more
doaj  

CASE OF HYDATIDIFORM MOLE. [PDF]

Journal of the American Medical Association, 1887
Dear Sir: —In the issue ofThe Journalof November 26, Dr. Thos. C. Smith, of Washington, D. C., reports two cases of "Hydatidiform Mole." As I also met with a case a short time since, and in many respects similar to the last of his cases, I beg to submit it to the profession. Mrs. W., aet. 41, white, has had six children. Previous history.
openaire   +2 more sources

Prevalence and Factors Associated with Hydatidiform Mole among Patients Undergoing Uterine Evacuation at Mbarara Regional Referral Hospital

Obstetrics and Gynecology International, 2018
Objective. We sought to determine the prevalence of and factors associated with hydatidiform molar gestations amongst patients undergoing uterine evacuation at Mbarara Regional Referral Hospital (MRRH), Mbarara, Uganda. Methods.
Olivier Mulisya, Drucilla J. Roberts, Elizabeth S. Sengupta, Elly Agaba, Damaris Laffita, Tusabe Tobias, Derrick Paul Mpiima, Lugobe Henry, Ssemujju Augustine, Masinda Abraham, Twizerimana Hillary, Julius Mugisha   +11 more
doaj   +1 more source

Management of Molar‐Pregnancy and Associated Gestational Trophoblastic Neoplasia at a Specialised Unit: 10‐Year Review

Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 1, February 2026.
ABSTRACT Patients diagnosed with gestational trophoblastic diseases (GTD) can develop malignant gestational trophoblastic neoplasia (GTN). ß‐hCG monitoring is important in the early detection of GTN. The primary outcome of this study was to describe ß‐hCG monitoring completion rates and time from GTN diagnosis to chemotherapy commencement for patients ...
Harrison Odgers, Shannon Philp, Trevor Tejada‐Berges   +2 more
wiley   +1 more source

The Creation of a Weight of Evidence Scoring Database for Risk Factors for Adverse Impacts to Birth Outcomes Using Expert Elicitation

Birth Defects Research, Volume 118, Issue 1, January 2026.
ABSTRACT Background Adverse birth outcomes are important public health measures and account for a substantial public health burden. There is considerable diversity of these health endpoints, as well as in the many factors suspected or recognized to increase their risk.
Paul J. Villeneuve, Ann Aschengrau, Michelle L. Bell, Yang Cao, Mark Elwood, Guy Eslick, Shelley Harris, Leeka Kheifets, Babak Khoshnood, Robert Norman, Nelson Pace, Johan Reutfors, Jeremy M. Schraw, Jose R. Suarez‐Lopez, Gunnar Toft, R. Douglas Wilson, Christopher R. Kirman, Tyler Carneal, Sean M. Hays   +18 more
wiley   +1 more source

Molecular cytogenetic analysis of a hydatidiform mole with coexistent fetus: a case report

Journal of Medical Case Reports, 2019
Background A hydatidiform mole with a coexisting fetus is a rare condition that commonly occurs as either a partial mole with fetus or a twin pregnancy comprising a complete mole and normal fetus.
Nozomi Uemura, Yasushi Takai, Yukiko Mikami, Miwa Ogasawara, Masahiro Saitoh, Kazunori Baba, Junichi Tamaru, Masaaki Hara, Hiroyuki Seki   +8 more
doaj   +1 more source

Placental chorangiomas: Diagnostic challenges and contemporary approaches to fetal care

Pregnancy, Volume 2, Issue 1, January 2026.
Abstract Placental chorangiomas are the most common benign tumors of the placenta. Although most are small and asymptomatic lesions, giant chorangiomas are associated with an increased risk of adverse maternal and fetal outcomes. Therefore, in those affected by giant placental chorangioma, early diagnosis and intensive fetal monitoring are indicated to
Tiffany E. Deihl, May Abiad, Enaja Sambatur, Nikan Zargarzadeh, Ramen H. Chmait, Alireza A. Shamshirsaz, Stephen P. Emery   +6 more
wiley   +1 more source